AzTrials
AzTrials

Colorectal SurgeryREDWILNCT01049971

REDWIL: Reduction of Wound Infections in Laparoscopic Colon Resections by Wound Protectors

A study testing wound protector and no wound protector in people with Colorectal Surgery and Wound Infections, run by Charite University, Berlin, Germany at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Surgical site infection is common in colorectal surgery leading to increased postoperative pain, longer hospital stay, delayed wound healing and increased re-operation rates. Hence, reducing the wound infection rate is a major aim in abdominal surgery. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Colorectal Surgery, Wound Infections
What is being tested?
wound protector and no wound protector
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
109 participants
Where
1 siteGermany
Study dates
Dec 2007to Jan 2011
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • elective laparoscopic colorectal resection with minilaparotomy

Who cannot join

  • emergency operation
  • patients under 18 years of age

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Charité Campus Benjamin Franklin; Hindenburgdamm 30

    Berlin, State of Berlin, 12200

Other trials in Germany

About this study

Official title: Reduction of Wound Infections in Laparoscopic Colon Resections by Wound Protectors

Surgical site infection is common in colorectal surgery leading to increased postoperative pain, longer hospital stay, delayed wound healing and increased re-operation rates. Hence, reducing the wound infection rate is a major aim in abdominal surgery.

Wound protectors were invented for retracting the abdominal wall and keeping the abdominal wall sterile in order to reduce bacterial colonialization of the wound and wound infections.

This is a prospective-randomized trial comparing use of wound protectors versus woven drapes in laparoscopic colon resections with minilaparotomy.

Being tested
wound protector, no wound protector
Keywords
colorectal surgery, wound infection, wound protector, laparoscopy, surgical site infection after laparoscopic colorectal surgery with minilaparotomy
Medical subject headings
Wound Infection

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • wound protectorDevice

    Also called Vi-Drape (Trademark) wound protector

    after minilaparotomy, the wound protector is applied

  • no wound protectorDevice

    use of woven drape instead of wound protector

Study groups in NCT01049971
Study groupRoleWhat they receive
no wound protectorActive comparatorinstead of wound protector, a woven drape is applied
Receives: Device: no wound protector
wound protectorExperimentalafter minilaparotomy, wound protector is applied
Receives: Device: wound protector

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. percentage of wound infections

    the total percentage of wound infections within 6 months postoperatively will be analyzed

    Measured: 6 months postoperatively

Secondary outcomes (4)
  1. colonialization of abdominal wall with bacteria

    a swab of the abdominal wall is taken before skin closure routinely in every participating patient and the bacteria found is analyzed

    Measured: 6 months postoperatively

  2. postoperative costs

    the costs for the operation, for the hospital stay including re-admissions, and for the outpatient stay is analyzed

    Measured: 6 months postoperatively

  3. length of hospital stay

    the total hospital stay including re-admissions is analyzed

    Measured: 6 months postoperatively

  4. cosmetic result

    the satisfaction with the cosmeti result is analyzed in every patient by questionnaire 6 months postoperatively

    Measured: 6 months postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jan 2010 (estimated)
  2. Study startDec 2007
  3. Primary completionJan 2011
  4. Study completionJan 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
109 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01049971
Sponsor's protocol ID
EA4/089/07
Acronym
REDWIL
Status last verified
Dec 2007
First submitted
14 Jan 2010
Last updated
7 Jul 2011
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing wound protector and no wound protector in people with Colorectal Surgery and Wound Infections, run by Charite University, Berlin, Germany at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jul 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

percentage of wound infections (time frame: 6 months postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in